研究等業績 - その他 - 三浦　昌朋

特集 急性白血病の薬物療法のupdate ～最新の診断・治療戦略～ ８.治療薬物モニタリング

三浦昌朋, 高橋直人

医薬ジャーナル ( 医薬ジャーナル社 )  54 ( 5 ) 1244 - 1248   2018年05月

DOI CiNii Research

A comparison of the effects of CYP3A5 polymorphism on tacrolimus blood concentrations measured by 4 immunoassay methods in renal transplant patients

Akamine Y.

Journal of Clinical Pharmacy and Therapeutics ( Journal of Clinical Pharmacy and Therapeutics )  43 ( 2 ) 181 - 188   2018年04月

DOI

An update on the clinical pharmacokinetics of fexofenadine enantiomers

Akamine Y.

Expert Opinion on Drug Metabolism and Toxicology ( Expert Opinion on Drug Metabolism and Toxicology )  14 ( 4 ) 429 - 434   2018年04月

DOI

Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma

Igarashi R.

Medical Oncology ( Medical Oncology )  35 ( 4 )   2018年04月

DOI

Correlation of plasma concentration and adverse effects of bosutinib: Standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

Mita A.

Experimental Hematology and Oncology ( Experimental Hematology and Oncology )  7 ( 1 )   2018年04月

DOI

Prediction of tacrolimus exposure by CYP3A5 genotype and exposure of co-administered everolimus in Japanese renal transplant recipients

Kagaya H.

International Journal of Molecular Sciences ( International Journal of Molecular Sciences )  19 ( 3 )   2018年03月

DOI

第Ⅲ部　治療における最近の新薬の位置付け〈薬効別〉～新薬の広場～ 免疫抑制剤

赤嶺由美子, 三浦昌朋

医薬ジャーナル ( 医薬ジャーナル社 )  54 ( 13 ) 519 - 525   2018年02月

DOI CiNii Research

Therapeutic drug monitoring of ponatinib using a simple high-performance liquid chromatography method in Japanese patients

Abumiya M.

Leukemia Research ( Leukemia Research )  64   42 - 45   2018年01月

DOI

がん治療時に遭遇する薬物相互作用とその対策を考える

三浦 昌朋, 富岡 佳久

日本医療薬学会年会講演要旨集 ( 一般社団法人 日本医療薬学会 )  28 ( 0 ) 352 - 357   2018年

DOI CiNii Research

Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non–small-cell Lung Cancer

Yokota H.

Clinical Lung Cancer ( Clinical Lung Cancer )  18 ( 6 ) e433 - e439   2017年11月

DOI

Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms

Akamine Y.

Annals of Clinical Biochemistry ( Annals of Clinical Biochemistry )  54 ( 6 ) 677 - 685   2017年11月

DOI

Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations

Niioka T.

Clinical and Experimental Nephrology ( Clinical and Experimental Nephrology )  21 ( 5 ) 787 - 796   2017年10月

DOI

Relationship between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N -Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients with Different CYP2C19 Genotypes

Niioka T.

Therapeutic Drug Monitoring ( Therapeutic Drug Monitoring )  39 ( 5 ) 514 - 521   2017年10月

DOI

Therapeutic strategy of tyrosine kinase inhibitors using plasma concentration

Miura M.

Japanese Journal of Clinical Chemistry ( Japanese Journal of Clinical Chemistry )  46 ( 4 ) 277 - 282   2017年10月

Plasma concentration of osimertinib in a non-small cell lung cancer patient with chronic renal failure undergoing hemodialysis

Tamura T.

Lung Cancer ( Lung Cancer )  112   225 - 226   2017年10月

DOI

Quantification of interstitial fibrosis in renal allografts and clinical correlates of long-Term graft function

Nara M.

American Journal of Nephrology ( American Journal of Nephrology )  46 ( 3 ) 187 - 194   2017年09月

DOI

Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival

Okuda Y.

Cancer Chemotherapy and Pharmacology ( Cancer Chemotherapy and Pharmacology )  79 ( 5 ) 1013 - 1020   2017年05月

DOI

Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib

Numakura K.

Anti-Cancer Drugs ( Anti-Cancer Drugs )  28 ( 1 ) 97 - 103   2017年01月

DOI

Effect of hepatic drug transporter polymorphisms on the pharmacokinetics of mycophenolic acid in patients with severe renal dysfunction before renal transplantation

Kagaya H.

Xenobiotica ( Xenobiotica )  47 ( 10 ) 916 - 922   2017年

DOI

免疫抑制薬TDM標準化ガイドラインversion2の策定と今後

増田 智先, 三浦 昌朋

日本医療薬学会年会講演要旨集 ( 一般社団法人 日本医療薬学会 )  27 ( 0 ) 236 - 244   2017年

DOI CiNii Research